Harfouche et al., 2012 - Google Patents
RrgB321, a fusion protein of the three variants of the pneumococcal pilus backbone RrgB, is protective in vivo and elicits opsonic antibodiesHarfouche et al., 2012
View PDF- Document ID
- 18174148399099120983
- Author
- Harfouche C
- Filippini S
- Gianfaldoni C
- Ruggiero P
- Moschioni M
- Maccari S
- Pancotto L
- Arcidiacono L
- Galletti B
- Censini S
- Mori E
- Giuliani M
- Facciotti C
- Cartocci E
- Savino S
- Doro F
- Pallaoro M
- Nocadello S
- Mancuso G
- Haston M
- Goldblatt D
- Barocchi M
- Pizza M
- Rappuoli R
- Masignani V
- Publication year
- Publication venue
- Infection and immunity
External Links
Snippet
Streptococcus pneumoniae pilus 1 is present in 30 to 50% of invasive disease-causing strains and is composed of three subunits: the adhesin RrgA, the major backbone subunit RrgB, and the minor ancillary protein RrgC. RrgB exists in three distinct genetic variants and …
- 108090001123 antibodies 0 title abstract description 41
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G01N33/56916—Enterobacteria, e.g. shigella, salmonella, klebsiella, serratia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
- C07K16/1228—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K16/1232—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia from Escherichia (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Giefing et al. | Discovery of a novel class of highly conserved vaccine antigens using genomic scale antigenic fingerprinting of pneumococcus with human antibodies | |
| Glover et al. | Streptococcus pneumoniae surface protein PcpA elicits protection against lung infection and fatal sepsis | |
| Harfouche et al. | RrgB321, a fusion protein of the three variants of the pneumococcal pilus backbone RrgB, is protective in vivo and elicits opsonic antibodies | |
| Choi et al. | Capsular polysaccharide (CPS) release by serotype 3 pneumococcal strains reduces the protective effect of anti-type 3 CPS antibodies | |
| Frost et al. | Correlates of immunity to Group A Streptococcus: a pathway to vaccine development | |
| McCool et al. | Serum immunoglobulin G response to candidate vaccine antigens during experimental human pneumococcal colonization | |
| Daniels et al. | The proline-rich region of pneumococcal surface proteins A and C contains surface-accessible epitopes common to all pneumococci and elicits antibody-mediated protection against sepsis | |
| Khan et al. | Vaccine candidates PhtD and PhtE of Streptococcus pneumoniae are adhesins that elicit functional antibodies in humans | |
| Usinger et al. | Avidity as a determinant of the protective efficacy of human antibodies to pneumococcal capsular polysaccharides | |
| Roche et al. | Live attenuated Streptococcus pneumoniae strains induce serotype-independent mucosal and systemic protection in mice | |
| Bagnoli et al. | A second pilus type in Streptococcus pneumoniae is prevalent in emerging serotypes and mediates adhesion to host cells | |
| McAdow et al. | Coagulases as determinants of protective immune responses against Staphylococcus aureus | |
| Frandoloso et al. | Nonbinding site-directed mutants of transferrin binding protein B exhibit enhanced immunogenicity and protective capabilities | |
| Roche et al. | Regions of PspA/EF3296 best able to elicit protection against Streptococcus pneumoniae in a murine infection model | |
| Lee et al. | Immune response in infants to the heptavalent pneumococcal conjugate vaccine against vaccine-related serotypes 6A and 19A | |
| Kallio et al. | Role of Pht proteins in attachment of Streptococcus pneumoniae to respiratory epithelial cells | |
| Concepcion et al. | Evaluation of previously assigned antibody concentrations in pneumococcal polysaccharide reference serum 89SF by the method of cross-standardization | |
| Shah et al. | Immunization with polyamine transport protein PotD protects mice against systemic infection with Streptococcus pneumoniae | |
| Peng et al. | Development of a lipopolysaccharide-targeted peptide mimic vaccine against Q fever | |
| Georgieva et al. | Antigenic variation in Streptococcus pneumoniae PspC promotes immune escape in the presence of variant-specific immunity | |
| Croney et al. | Invasive and noninvasive Streptococcus pneumoniae capsule and surface protein diversity following the use of a conjugate vaccine | |
| Ochs et al. | Vaccine-induced human antibodies to PspA augment complement C3 deposition on Streptococcus pneumoniae | |
| Cardaci et al. | Protective activity of Streptococcus pneumoniae Spr1875 protein fragments identified using a phage displayed genomic library | |
| Lu et al. | Protective immune responses elicited by fusion protein containing PsaA and PspA fragments | |
| Xin et al. | PspA family fusion proteins delivered by attenuated Salmonella enterica serovar Typhimurium extend and enhance protection against Streptococcus pneumoniae |